NBP2001
/ SK Bio
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
April 18, 2023
Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)
(clinicaltrials.gov)
- P1 | N=50 | Completed | Sponsor: SK Bioscience Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • IL4
February 18, 2021
Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)
(clinicaltrials.gov)
- P1; N=50; Active, not recruiting; Sponsor: SK Bioscience Co., Ltd.
Clinical • New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • IL4
June 01, 2020
"@OakRidgeOffice @ORCID_Org @SenateDems @SenateGOP @realDonaldTrump @BarackObama @GSK_bio @LibraryOfMed Meet your mourder, he es the one who contributed to your little gift COVID-19"
(@ditz_erick)
Infectious Disease • Novel Coronavirus Disease
May 05, 2020
"#COVID19vaccine #TrumpOwnsEveryDeath @funder @TomPerez @SpeakerPelosi @JoeBiden @RepSwalwell @SenKamalaHarris @SenSchumer @GOP @CDCgov @US_FDA @InovioPharma @GSK_bio @USMerckProducts @Merck @pfizer"
(@KathyGrants)
Infectious Disease • Novel Coronavirus Disease
April 24, 2020
"@pfizer @sanofipasteur @GSK_bio A P50M reward for covid19 vaccine. @WHO @CDCgov"
(@JudeAbarquez)
Infectious Disease • Novel Coronavirus Disease
April 14, 2020
"Collaboration has never been so meaningful to fight #COVID19 @SanofiFR @GSK_bio"
(@IGrosmaitre)
Infectious Disease • Novel Coronavirus Disease
April 13, 2020
"Special guest Jim Brase of @Livermore_Lab details how #supercomputing is battling #COVID19 - full podcast at https://t.co/kTGbclblaR @UCSF @GSK_bio @theNCI #HPC #COVIDー19"
(@ThisWeekinHPC)
April 02, 2020
"Well done @GSK_bio #Worthing stepping up to tackle #COVID19Pandemic #bbcqt #COVIDー19 #clapforkeyworkers @MattHancock"
(@CoolTownCrier)
March 23, 2020
SK Bioscience starts animal trial of COVID-19 vaccine
(Korea Biomedical Review)
- "SK Bioscience said that it has succeeded in discovering a vaccine candidate for COVID-19 and started the animal clinical trial of the candidate substance."
Clinical
1 to 9
Of
9
Go to page
1